Stable, oral compound pharmaceutical containing pharmaceutically permissible content of [(E)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3R,5S)-3,5-dihydroxy-hept-6-enoate acid salt
PL385356A1
Method of tadalaphil production
PL385264A1
Method of production of enantiomerically pure (S)-1-phenyl-1, 2, 3, 4-tetrahydroizochinoline
PL385265A1
Method of production of soliphenacin and/or its salts of high pharmaceutical purity
PL384680A1
Pharmaceutical composition containing cylexyethyl candesarthan and its production method
PL382397A1
Heat tableting method using low compression forces
PL382346A1
The manner of production of salt of 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-ethenylo)phenylo)-3-(2-(1-hydroxy-1- methyloethylo)phenylo)propylo)sulphanylo)methylo)-cyclopropaiacetic acid
PL382311A1
Pharmaceutical composition with improved stability containing inhibitor of acethylolinoesterasis or its pharmaceutically admitted salt and its production method
PL382084A1
Amorphous carvedilol phosphate and production method
PL381344A1
Quickly disintegrating pill and method for its manufacture
PL379904A1
Pharmeceutical composition containing topiramate or its pharmaceutically admitted salt and its production method
PL379831A1
Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process
PL378463A1
Method for the manufacture of aripiperazole in pharmaceutically useful polymorphic forms
PL378143A1
Pharmaceutical compound of fructopyranose 2,3:4,5-bis -O-(1-methylethylidiene) -D-amidosulphonate with improved stability as well as method for the manufacture of this compound
PL376857A1
Method for the manufacture of high-purity pioglitazone hydrochloride
PL345430A1
Pharmacological preparation exhibiting antiphlogistic and antifebrile properties
